Pharmacokinetics, pharmacodynamics, safety and tolerability of 4 weeks' treatment with empagliflozin in Japanese patients with type 2 diabetes mellitus

INTRODUCTION: To evaluate the pharmacodynamics, pharmacokinetics, safety and tolerability of empagliflozin in Japanese patients with type 2 diabetes mellitus. MATERIALS AND METHODS: In this 4‐week, multiple dose, randomized, parallel‐group, double‐blind, placebo‐controlled trial, patients (n = 100)...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanada, Shigeto, Koiwai, Kazuki, Taniguchi, Atsushi, Sarashina, Akiko, Seman, Leo, Woerle, Hans J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley-Blackwell 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020257/
https://www.ncbi.nlm.nih.gov/pubmed/24843716
http://dx.doi.org/10.1111/jdi.12110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020257/
https://www.ncbi.nlm.nih.gov/pubmed/24843716
http://dx.doi.org/10.1111/jdi.12110

Ejemplares similares